HyperCVAD/HD MTX AraC Regimen

Known as: Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone/High-dose Methotrexate-Cytarabine Regimen 
A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone (Hyper-CVAD) administered on a hyperfractionated schedule… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2016
012319972016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or… (More)
  • table 1
  • figure 3
  • figure 4
  • figure 1
  • figure 2
Is this relevant?
2011
2011
Mantle cell lymphoma (MCL) is challenging to manage, with a median survival of 3-5 years. While intensive strategies are often… (More)
Is this relevant?
2010
2010
Mantle cell lymphoma (MCL) outcomes have improved over the last two decades; however, late relapses occur. Bortezomib has shown… (More)
Is this relevant?
2010
2010
Chemotherapy induced thrombopenia (CIT) is difficult to treat, as previous treatment options, including recombinant human… (More)
  • figure 1
Is this relevant?
2009
2009
Case 1 A 45-year-old male patient with mantle cell lymphoma was treated with four courses of R-hyperCVAD (October 2000–August… (More)
  • table 1
  • figure 1
Is this relevant?
2008
2008
Mantle cell lymphoma (MCL) is a B-cell lymphoid tumor that expresses CD20 and is associated with a poor prognosis. Central… (More)
Is this relevant?
2008
2008
INTRODUCTION Despite therapeutic advances, acute lymphoblastic leukemia (ALL) in adults remains a disease with poor long term… (More)
Is this relevant?
2006
2006
BACKGROUND There is no standard first line treatment for mantle cell lymphoma. PATIENTS AND METHODS This was a multicenter… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2003
2003
Small non-cleaved cell lymphomas (SNCL) as coined initially by Lukes and Collins and as used in the Working Formulation encompass… (More)
  • figure 1
  • figure 1
Is this relevant?
1997
1997
Twenty-seven patients with cervical metastases from squamous cell head and neck tumours were treated with hyperfractionated XRT… (More)
Is this relevant?